Global Leaders in Mobile  ECG Connectivity

• 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
• Sold into > 20 countries, with the largest customer base located in the US
• Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
• ECG solutions for both consumer (OTC) and medical (Rx) markets
• Owns all IP and source code
• Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Highlights

• Secured New Health Canada Device Clearance and Exclusive Canadian Sales Rights for US Medical ECG Device Manufacturer Read More
  • Entered into an exclusive sales and marketing agreement for the GEMS™ Sirona with California-based Datrix LLC
  • Under the multi-year, renewable agreement, CardioComm assumes the role of exclusive Canadian distributor of the Datrix ECG recorders under the GEMS™ Sirona brand device.
• Secured Newest US and Canadian Medical Device 13485:2016 MDSAP Certification Read More
  
  • Completed its ISO 13485:2016 certification in compliance with the Medical Device Single Audit Program, a mandatory requiment under Health Canada and accepted as an equivalent quality management certification by the USA Food and Drug Administration.
• Announced ECG Services Integration and Co-Marketing Agreement with California-Based BodiMetrics LLC Read More
  
  • GEMS™ Universal will be available under two subscription models:
  • $6 US per month with one free ECG interpretation included; and,
  • $69 US per year with 12 free ECG interpretations that may be requested any time during the one year subscription.

Company Accolades

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.